Cargando…
Membranous CD44v6 is upregulated as an early event in colorectal cancer: Downregulation is associated with circulating tumor cells and poor prognosis
Previous studies have reported that CD44 variant 6 (CD44v6) and metastasis-associated protein 1 (MTA1) are contributing factors to cancer progression. The present study aimed to evaluate the expression profiles for associations with patients' demographic data, clinicopathological characteristic...
Autores principales: | Kataki, Agapi, Giannakoulis, Vassilis G., Derventzi, Anastasia, Papiris, Konstantinos, Koniaris, Eythimios, Konstadoulakis, Manousos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527563/ https://www.ncbi.nlm.nih.gov/pubmed/34691247 http://dx.doi.org/10.3892/ol.2021.13081 |
Ejemplares similares
-
Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective
por: Giannakoulis, Vassilis G., et al.
Publicado: (2021) -
The Metastatic Process through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy
por: Smolkova, Bozena, et al.
Publicado: (2022) -
Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?
por: Earl, Julie, et al.
Publicado: (2023) -
Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients
por: Yan, Shushan, et al.
Publicado: (2017) -
Upregulator of Cell Proliferation Predicts Poor Prognosis in Hepatocellular Carcinoma and Contributes to Hepatocarcinogenesis by Downregulating FOXO3a
por: Xie, Chan, et al.
Publicado: (2012)